150 related articles for article (PubMed ID: 16287259)
1. Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo.
Okamura Y; Maekawa I; Teramura Y; Maruyama H; Handa M; Ikeda Y; Takeoka S
Bioconjug Chem; 2005; 16(6):1589-96. PubMed ID: 16287259
[TBL] [Abstract][Full Text] [Related]
2. Prolonged hemostatic ability of polyethylene glycol-modified polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide.
Okamura Y; Fujie T; Maruyama H; Handa M; Ikeda Y; Takeoka S
Transfusion; 2007 Jul; 47(7):1254-62. PubMed ID: 17581161
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic effects of fibrinogen gamma-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivo.
Okamura Y; Takeoka S; Teramura Y; Maruyama H; Tsuchida E; Handa M; Ikeda Y
Transfusion; 2005 Jul; 45(7):1221-8. PubMed ID: 15987370
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic effects of polymerized albumin particles carrying fibrinogen gamma-chain dodecapeptide as platelet substitutes in severely thrombocytopenic rabbits.
Okamura Y; Fujie T; Nogawa M; Maruyama H; Handa M; Ikeda Y; Takeoka S
Transfus Med; 2008 Jun; 18(3):158-66. PubMed ID: 18598278
[TBL] [Abstract][Full Text] [Related]
5. Novel platelet substitutes: disk-shaped biodegradable nanosheets and their enhanced effects on platelet aggregation.
Okamura Y; Fukui Y; Kabata K; Suzuki H; Handa M; Ikeda Y; Takeoka S
Bioconjug Chem; 2009 Oct; 20(10):1958-65. PubMed ID: 19788180
[TBL] [Abstract][Full Text] [Related]
6. Release abilities of adenosine diphosphate from phospholipid vesicles with different membrane properties and their hemostatic effects as a platelet substitute.
Okamura Y; Katsuno S; Suzuki H; Maruyama H; Handa M; Ikeda Y; Takeoka S
J Control Release; 2010 Dec; 148(3):373-9. PubMed ID: 20875473
[TBL] [Abstract][Full Text] [Related]
7. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
[TBL] [Abstract][Full Text] [Related]
8. Function of fibrinogen gamma-chain dodecapeptide-conjugated latex beads under flow.
Takeoka S; Okamura Y; Teramura Y; Watanabe N; Suzuki H; Tsuchida E; Handa M; Ikeda Y
Biochem Biophys Res Commun; 2003 Dec; 312(3):773-9. PubMed ID: 14680832
[TBL] [Abstract][Full Text] [Related]
9. Ability of fibrinogen γ-derived dodecapeptides with different sequences to bind to rat platelets.
Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
Int J Pharm; 2012 Nov; 438(1-2):296-301. PubMed ID: 22985603
[TBL] [Abstract][Full Text] [Related]
10. Decoration of fibrinogen γ-chain peptide on adenosine diphosphate-encapsulated liposomes enhances binding of the liposomes to activated platelets.
Tokutomi K; Tagawa T; Korenaga M; Chiba M; Asai T; Watanabe N; Takeoka S; Handa M; Ikeda Y; Oku N
Int J Pharm; 2011 Apr; 407(1-2):151-7. PubMed ID: 21251962
[TBL] [Abstract][Full Text] [Related]
11. Ultrastructural analysis of thrombin-induced interaction between human platelets and liposomes carrying fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
Suzuki H; Okamura Y; Ikeda Y; Takeoka S; Handa M
Thromb Res; 2011 Dec; 128(6):552-9. PubMed ID: 21840573
[TBL] [Abstract][Full Text] [Related]
12. A defined peptide that inhibits the formation of the glycoprotein IIb and IIIa complex.
Chiang TM; Zhu J
Thromb Res; 2005; 115(6):503-8. PubMed ID: 15792682
[TBL] [Abstract][Full Text] [Related]
13. New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen gamma-chain dodecapeptide- or glycoprotein Ibalpha-conjugated latex beads under flow conditions.
Okamura Y; Handa M; Suzuki H; Ikeda Y; Takeoka S
J Artif Organs; 2006; 9(4):251-8. PubMed ID: 17171404
[TBL] [Abstract][Full Text] [Related]
14. Development of fibrinogen gamma-chain peptide-coated, adenosine diphosphate-encapsulated liposomes as a synthetic platelet substitute.
Okamura Y; Takeoka S; Eto K; Maekawa I; Fujie T; Maruyama H; Ikeda Y; Handa M
J Thromb Haemost; 2009 Mar; 7(3):470-7. PubMed ID: 19143920
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes rescue thrombocytopenic rabbits from non-compressible liver hemorrhage.
Nishikawa K; Hagisawa K; Kinoshita M; Shono S; Katsuno S; Doi M; Yanagawa R; Suzuki H; Iwaya K; Saitoh D; Sakamoto T; Seki S; Takeoka S; Handa M
J Thromb Haemost; 2012 Oct; 10(10):2137-48. PubMed ID: 22905905
[TBL] [Abstract][Full Text] [Related]
16. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
Taguchi K; Hashimoto M; Ogaki S; Watanabe H; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
J Pharm Sci; 2015 Sep; 104(9):3084-91. PubMed ID: 25755009
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of hemoglobin vesicles with poly(ethylene glycol) and effects on aggregation, viscosity, and blood flow during 90% exchange transfusion in anesthetized rats.
Sakai H; Takeoka S; Park SI; Kose T; Nishide H; Izumi Y; Yoshizu A; Kobayashi K; Tsuchida E
Bioconjug Chem; 1997; 8(1):23-30. PubMed ID: 9026031
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic study of the structural components of adenosine diphosphate-encapsulated liposomes coated with fibrinogen γ-chain dodecapeptide as a synthetic platelet substitute.
Taguchi K; Ujihira H; Ogaki S; Watanabe H; Fujiyama A; Doi M; Okamura Y; Takeoka S; Ikeda Y; Handa M; Otagiri M; Maruyama T
Drug Metab Dispos; 2013 Aug; 41(8):1584-91. PubMed ID: 23735758
[TBL] [Abstract][Full Text] [Related]
19. Lysine-PEG-modified polyurethane as a fibrinolytic surface: Effect of PEG chain length on protein interactions, platelet interactions and clot lysis.
Li D; Chen H; Glenn McClung W; Brash JL
Acta Biomater; 2009 Jul; 5(6):1864-71. PubMed ID: 19342321
[TBL] [Abstract][Full Text] [Related]
20. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
